BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2908815)

  • 21. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs.
    Polak MJ; Drummond WH
    Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.
    Hughes A; Thom S; Martin G; Redman D; Hasan S; Sever P
    Br J Clin Pharmacol; 1986 Nov; 22(5):535-40. PubMed ID: 2878679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal and endocrine effects of fenoldopam and metoclopramide in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Nephron; 1990; 56(2):179-85. PubMed ID: 1978736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
    Kinter LB; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1994; 6(5):446-55. PubMed ID: 7915128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation.
    Pollock DM; Arendshorst WJ
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F627-35. PubMed ID: 1969238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1990 Apr; 29(4):413-5. PubMed ID: 1970264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
    Wang YX; Gellai M; Brooks DP
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
    Horn PT; Kohli JD
    Eur J Pharmacol; 1991 May; 197(2-3):125-30. PubMed ID: 1680707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
    Woodman OL; Rechtman MP; Lang WJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):203-11. PubMed ID: 6971630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
    Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of fenoldopam on intracranial pressure and hemodynamic variables at normal and elevated intracranial pressure in anesthetized pigs.
    Hennes HJ; Jantzen JP
    J Neurosurg Anesthesiol; 1994 Jul; 6(3):175-81. PubMed ID: 7915922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
    Kopia GA; Valocik RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine.
    Shi Y; Zalewski A; Bravette B; Maroko AR; Maroko PR
    Am Heart J; 1992 Aug; 124(2):418-23. PubMed ID: 1353297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats.
    Meyer ME; Van Hartesveldt C; Potter TJ
    Synapse; 1993 Apr; 13(4):310-4. PubMed ID: 8097596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans.
    Horton R; Bughi S; Jost-Vu E; Antonipillai I; Nadler J
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):108S-111S. PubMed ID: 1974438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
    Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W
    J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of tubuloglomerular feedback by the D1 agonist fenoldopam in chronically salt-loaded rats.
    Häberle DA; Königbauer B
    J Physiol; 1991 Sep; 441():23-34. PubMed ID: 1687747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries.
    Hughes AD; Sever PS
    Br J Pharmacol; 1989 Jul; 97(3):950-6. PubMed ID: 2474354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.